Skip to search formSkip to main contentSkip to account menu

Antineoplastic Combined Chemotherapy Protocols

Known as: Drug Combinations, Antineoplastic, Agents, Combined Antineoplastic, Antineoplastic Drug Combination 
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
National Institutes of Health

Related topics

Related topics

50 relations

Narrower (49)

ACP protocolB-DOMP protocolCCV protocolCE-AVN protocol
antagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
6 – Drug combinations
  • D. Lu
  • 2015
  • Corpus ID: 68177322
Review
2015
Review
2015
Anticancer drug combinations : The next medical challenge
Since most cancers have multiple genetic alterations and molecular abnormalities, it is seldom very useful by using therapeutics… 
2013
2013
Tubulin‐targeting agent combination therapies: dosing schedule could matter
Tubulin‐binding agents are potent cytotoxic drugs that are largely used to treat haematological malignancies and solid tumours… 
Highly Cited
2005
Highly Cited
2005
Role of Intracellular Glutathione in Cell Sensitivity to the Apoptosis Induced by Tumor Necrosis Factor α–Related Apoptosis-Inducing Ligand/Anticancer Drug Combinations
Purpose: We have recently shown that combination of tumor necrosis factor α–related apoptosis-inducing ligand (TRAIL) with… 
Highly Cited
2004
Highly Cited
2004
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the…
Breast cancer has a significant capacity to metastasize to bone. Bisphosphonates are the standard treatment for hypocalcaemia of… 
2003
2003
Apoptosis enzyme-linked immunosorbent assay distinguishes anticancer drugs from toxic chemicals and predicts drug synergism.
2002
2002
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving…
BACKGROUND Patients with advanced esophageal cancer are frequently not indicated for intensive chemotherapy due to aero-digestive… 
1999
1999
Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide.
In an effort to use antineoplastic drug combinations which are active in platinum resistant ovarian cancer or which can induce a… 
1999
1999
In vitro toxicity of taxol based anticancer drug combinations on human hemopoietic progenitors.
The sequence dependency of the interaction of taxol with other anticancer drugs is of clinical importance, and may be due to… 
1984
1984
Toxicity of antineoplastic drug combinations in vitrectomy infusion fluid.
We evaluated a combination of various antineoplastic drugs used in vitrectomy infusion fluid for toxicity. A combination of 250… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)